Protagonist Therapeutics Inc sell StockNews.com
Start price
18.10.23
/
50%
€21.80
Target price
18.10.24
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 18.10.24. The prediction end date can be changed by StockNews_com at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Protagonist Therapeutics Inc | - | - |
iShares Core DAX® | 0.443% | 0.771% |
iShares Nasdaq 100 | -0.150% | 4.094% |
iShares Nikkei 225® | 2.566% | 4.202% |
iShares S&P 500 | 0.479% | 2.881% |
Comments by StockNews_com for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by StockNews_com for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€21.80
30.09.23
30.09.23
-
30.09.24
30.09.24
-
24.02.22
24.02.22